ANDA 61734, held by Wyeth Ayerst. Tetracycline Hydrochloride.
As of Nov 16, 2026, ANDA 61734 (Robitet), held by Wyeth Ayerst, was not approved, with 0 approved supplements and 0 published complete response letters.
| Robitet250MG · capsule;oral | Tetracycline Hydrochloride | Discontinued |
| Robitet500MG · capsule;oral | Tetracycline Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters